Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.
about
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementA Metabolomic Approach to Understanding the Metabolic Link between Obesity and DiabetesA Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic AgenHolistic approach to prevention and management of type 2 diabetes mellitus in a family setting.Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.Prediabetes: The Variation between HbA1c and Fasting Plasma Glucose.Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach.Antidiabetic activity of Pterospermum acerifolium flowers and glucose uptake potential of bioactive fraction in L6 muscle cell lines with its HPLC fingerprint.Personalizing guidelines for diabetes management: twilight or dawn of the expert?Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (a retrospective analysis of the EUROACTION trial).Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes.Targeting metabolic disorders by natural products.Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy.Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.Effect of single oral dose of proanthocyanidin on postprandial hyperglycemia in healthy rats: A comparative study with sitagliptinSelf-monitoring of blood glucose: one STeP forward?Glycaemic Control and Associated Self-Management Behaviours in Diabetic Outpatients: A Hospital Based Observation Study in Lusaka, Zambia.Pioglitazone acutely reduces energy metabolism and insulin secretion in ratsEffects of high-protein versus high-carbohydrate diets on markers of β-cell function, oxidative stress, lipid peroxidation, proinflammatory cytokines, and adipokines in obese, premenopausal women without diabetes: a randomized controlled trialTransplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice.Frequency, severity and risk indicators of retinopathy in patients with diabetes screened by fundus photographs: a study from primary health care.Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors.Mouse models and type 2 diabetes: translational opportunities.Oral antidiabetic drug therapy in type 2 diabetes mellitus - focus on elderly patients.Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus.Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes.Sulfonylureas: a new look at old therapy.Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes.Adiponectin gene polymorphisms and susceptibility to diabetic nephropathy: a meta-analysis.Effect of Commiphora mukul gum resin on hepatic marker enzymes, lipid peroxidation and antioxidants status in pancreas and heart of streptozotocin induced diabetic rats.Association of SLC30A8 gene polymorphism with type 2 diabetes, evidence from 46 studies: a meta-analysis.Utilization of model-based meta-analysis to delineate the net efficacy of taspoglutide from the response of placebo in clinical trials.Effect of Preadmission Metformin Use on Clinical Outcome of Acute Respiratory Distress Syndrome among Critically Ill Patients with DiabetesEvaluation of pharmacokinetic drug interactions between gemigliptin (dipeptidylpeptidase-4 inhibitor) and glimepiride (sulfonylurea) in healthy volunteersEffectiveness of prediabetes nutrition shared medical appointments: prevention of diabetes.Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats.Sevoflurane Induces Exaggerated and Persistent Cognitive Decline in a Type II Diabetic Rat Model by Aggregating Hippocampal Inflammation.Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir.
P2860
Q22241288-EFB547C7-3A45-470A-A90F-45FF44395948Q26783199-C54C01C6-FA0C-42E6-9190-7FCD6644E7D2Q28083355-674E0EB4-24A4-4776-B8B9-C0F9C746F12AQ28552837-66D00D7C-0582-4AAA-801A-AF2A1E23D39DQ33706603-7CDC7B1E-DDA0-4A72-80B8-19A00C12D8E5Q33754815-D5A9AE45-0636-4764-AF36-7F3915B89944Q33768831-B1F2042B-B11A-4327-9360-B57C20E5C4BAQ33805824-EE399DF6-A7EF-4209-920F-0CD59153D99FQ34461266-AD41F03C-6297-4653-BB5A-FBFED09E5D58Q34810165-630F2676-2C45-490C-8AB2-388F9FB9F4DBQ35167022-8755C147-F636-4DC6-A1F9-0A92D403CA28Q35548033-6A5F3574-2349-44BA-A7F8-6B2BC52D18FDQ35830892-1F025CEF-1420-4D5D-AD0A-A79F0216A577Q35971304-EF78936C-A899-4E91-B119-2EF5EEA039A1Q35976735-F8B1A72C-B3BB-4D3F-A9AE-134EF34A978CQ36078084-784664D3-4535-4851-B371-6834EFE910FFQ36229360-7AF78EB4-C496-495F-ABEE-186FDBE87914Q36424142-8AB9878D-1EDF-4088-88D8-91BA6ED05E1BQ36867430-969A8067-6897-4EDC-A96B-64BE2A70AB8FQ36942211-D10DDD06-E70F-4F31-AA66-602A94ED84CFQ37714129-E5D50C35-9E21-4F34-9227-36DCA66A82C7Q37722030-3E58A870-52BE-49A3-9459-69B992B04B72Q37728361-7213D745-180F-4F62-8B5D-C7D403969B9DQ37895535-FCCFFDCB-1AA3-49BC-B1B6-66065DE8485AQ37902580-B8C4621A-B51D-4F6E-A776-3DD77857ABB9Q37941683-D9F797E7-1D9F-48A0-B77C-1F6BD2C822D4Q38190465-29499849-C66D-4DA3-A70F-0CF51E5C82A0Q38190489-B6268305-679C-49D6-A6C8-C37538DE3159Q38668559-96B5D44E-482E-4409-B1D7-9D0B5ED41A1CQ39205071-7A4539DE-02D8-4F55-9074-F759121158C4Q39293471-429932CD-7F7D-4097-B304-92EEED45198FQ39336937-A2A7826B-F326-44DA-8B37-D65E53B2E393Q40035575-8FF88EFE-4F69-4ACD-BB35-223E5C2022FBQ40803439-2775E8A7-BD74-4AFF-9591-5A2A0C058686Q41124317-9099E186-75FA-4575-9C43-5905531C0B50Q41958385-4065AB14-47FC-49EA-8C2D-B833C8EF1E4BQ42595274-E0EFE25C-1EFD-48CC-BA26-A77BE6B2B876Q43648419-D8C595FB-3240-4DED-AD0F-D7A7E7245A5BQ47115126-14CA5817-FDF7-49FD-A866-6F8C24876CD7Q47745734-AAD487DB-1319-42A9-BEB3-4806B3C49804
P2860
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of type 2 diabetes: ...... patients with type 2 diabetes.
@en
Management of type 2 diabetes: ...... patients with type 2 diabetes.
@nl
type
label
Management of type 2 diabetes: ...... patients with type 2 diabetes.
@en
Management of type 2 diabetes: ...... patients with type 2 diabetes.
@nl
prefLabel
Management of type 2 diabetes: ...... patients with type 2 diabetes.
@en
Management of type 2 diabetes: ...... patients with type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
Management of type 2 diabetes: ...... patients with type 2 diabetes.
@en
P2093
Ebenezer A Nyenwe
Guillermo E Umpierrez
Terri W Jerkins
P2860
P356
10.1016/J.METABOL.2010.09.010
P577
2011-01-01T00:00:00Z